Boryung Pharma to release hypertension medication in S. America
Sept 26, 2016
[THE INVESTOR] South Korea’s Boryung Pharmaceutical has signed a contract with Mexican firm Stendhal International to supply medicine for treating hypertension in South America, the firm said on Sept. 26. The agreement is worth 30 billion won (US$27.1 million) -- which is 7.48 percent of the firm’s revenue in 2015. Boryung plans to gradually release more products in South America by 2024 via its partnership with Stendhal. The Korean firm has been seeking to expand into more markets for its oral